Spicing it up: Pro-drug curcumin shows clinical potential in mice
A prodrug form of curcumin, TBP1901, has shown anti-tumor effects without toxicities. The enzyme GUSB was identified for its key role in TBP1901 conversion to curcumin, which also has essential therapeutic targets.
Materials provided by Kyoto University. Note: Content may be edited for style and length.
Source link aaaaa